Showing 8061-8070 of 18595 results for "".
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
https://reachmd.com/programs/project-oncology/modern-management-of-ros1-positive-non-small-cell-lung-cancer/54574/Light-Based Therapies for Alopecia: What’s Established and What’s Emerging
https://reachmd.com/programs/dermconsult/light-based-therapies-alopecia-established-emerging/49024/Modern Approaches to Long-Term Metastatic Breast Cancer Care
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/long-term-metastatic-breast-cancer-care/48712/Advances in systemic therapies have transformed metastatic breast cancer into a long-term, treatable condition for many patients. Learn more as Dr. Charles Turck sits down with Dr. Adam Brufsky to discuss how we can support these patients by prioritizing quality of life, addressing long-term toxicitEarly Liquid Biopsy in Advanced Lung Cancer: Real-World Data Suggest Targeted Gains
https://reachmd.com/programs/project-oncology/early-liquid-biopsy-in-advanced-lung-cancer-real-world-data-suggest-targeted-gains/39033/Current and Emerging Treatments for Transthyretin Amyloid Cardiomyopathy
https://reachmd.com/programs/heart-matters/current-and-emerging-treatments-for-transthyretin-amyloid-cardiomyopathy/36139/Treatment options for transthyretin amyloid cardiomyopathy have expanded significantly in recent years, moving from no approved therapies to multiple agents across distinct mechanistic classes. Join Dr. Ahmad Masri, Associate Professor of Medicine in the Division of Cardiovascular Medicine at OregonCost-Effectiveness of Universal vs. Selective Screening for ATTR-CM in HFpEF Patients
https://reachmd.com/programs/heart-matters/cost-effectiveness-of-universal-vs-selective-screening-for-attr-cm-in-hfpef-patients/32421/Hear about economic considerations in universal vs. selective screening for ATTR-CM in patients with heart failure with preserved ejection fraction.Diagnosing and Managing Psoriasis: What Primary Care Providers Need to Know
https://reachmd.com/programs/clinicians-roundtable/diagnosing-and-managing-psoriasis-what-primary-care-providers-need-to-know/32445/Learn how primary care providers can effectively diagnose, manage, and support patients with psoriasis.Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
https://reachmd.com/programs/neurofrontiers/debunking-misconceptions-regarding-the-revised-alzheimers-diagnostic-criteria/29096/Tune in to hear an expert address common misconceptions associated with the recently revised diagnostic and staging criteria for Alzheimer’s disease.Understanding the Cellular Basis for Altered Cognition in Schizophrenia
https://reachmd.com/programs/neurofrontiers/understanding-the-cellular-basis-for-altered-cognition-in-schizophrenia/17873/What’s the significance of somatostatin messenger RNA levels in the dorsolateral prefrontal cortex in schizophrenia? Tune in to find out.MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
https://reachmd.com/programs/neurofrontiers/ms-research-using-epigenetic-clocks-and-biomarkers-to-assess-biological-aging/18038/Find out how biomarkers like p16 and the epigenetic clock can be used to assess biological aging in patients with multiple sclerosis.